Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site, 2: Relevance of an N-terminal helix

被引:7
|
作者
Oliva, R
Falcigno, L
D'Auria, G
Dettin, M
Scarinci, C
Pasquato, A
Di Bello, C
Paolillo, L
机构
[1] Univ Naples Federico II, Dipartimento Chim, I-80126 Naples, Italy
[2] Univ Naples Federico II, CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy
[3] Univ Padua, Dipartimento Proc Chim Ingn, I-35131 Padua, Italy
关键词
conformation analysis; gp160; HIV; molecular modeling; NMR spectroscopy;
D O I
10.1002/cbic.200200541
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteolytic activation of the HIV-1 envelope glycoprotein gp160 is selectively performed by the proprotein convertase furin at the C terminus of the sequence R508-E-K-R511 (site 1), in spite of the presence of another consensus sequence, Lys500-Ala-Lys-Arg503 (site 2). On the basis of the solution structural analysis of the synthetic peptide p498, spanning the gp160 sequence Pro498-Gly516, we previously suggested a possible role of an N-terminal helix in regulating the exposure and accessibility of the gp160 physiological cleavage site, enclosed in a loop. Here we report on the activity and conformation of the 23 residue peptide h-REKR, designed to exhibit a large N terminal helix, followed by the gp160 native sequence, Arg508-Gly516, h-REKR is digested by furin with high efficiency comparable to the full native p498. Circular dichroism analyses, in mixtures from pure water to 98% trifluoroethanol, outline a significant content of helical structure in the peptide conformation. The molecular model obtained from NMR data collected in trifluoroethanol/water, by means of DYANA and AMBER simulations, indeed has helical structure on a large N-terminal segment. Such a long helix does not seem to affect the loop conformation of the C-terminal site 1-containing sequence, which exhibits the same proton chemical shifts already observed for the full native p498.
引用
收藏
页码:727 / 733
页数:7
相关论文
共 50 条
  • [31] Linear epitope mapping of humoral responses induced by vaccination with recombinant HIV-1 envelope protein gp160
    LoomisPrice, LD
    Levi, M
    Burnett, PR
    vanHamont, JE
    Shafer, RA
    Wahren, B
    Birx, DL
    JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 1997, 19 (01): : 58 - 65
  • [32] Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): Effects of administration of Zidovudine in vivo and interleukin-2 in vitro
    Pierdominici, M
    Mollicone, B
    Ricci, G
    Oliva, A
    D'Offizi, G
    Giovannetti, A
    Aiuti, F
    Pandolfi, F
    VACCINE, 1998, 16 (07) : 715 - 721
  • [33] Structural requirements of glycosaminoglycans for their interaction with HIV-1 envelope glycoprotein gp120
    Matos, Pedro M.
    Andreu, David
    Santos, Nuno C.
    Gutierrez-Gallego, Ricardo
    ARCHIVES OF VIROLOGY, 2014, 159 (03) : 555 - 560
  • [34] Structural requirements of glycosaminoglycans for their interaction with HIV-1 envelope glycoprotein gp120
    Pedro M. Matos
    David Andreu
    Nuno C. Santos
    Ricardo Gutiérrez-Gallego
    Archives of Virology, 2014, 159 : 555 - 560
  • [35] IMMUNIZATION OF CHIMPANZEES WITH THE HIV-1 GLYCOPROTEIN GP160 INDUCES LONG-LASTING T-CELL MEMORY
    MANNHALTER, JW
    PUM, M
    WOLF, HM
    KUPCU, Z
    BARRETT, N
    DORNER, F
    EDER, G
    EIBL, MM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (05) : 485 - 493
  • [36] HIV-1 ENVELOPE GLYCOPROTEINS, GP120 AND GP160, INDUCE INTERLEUKIN-6 PRODUCTION FROM T-CELLS
    OHNISHI, Y
    CHIRMULE, N
    OYAIZU, N
    KALYANARAMAN, VS
    PAHWA, S
    FASEB JOURNAL, 1991, 5 (05): : A1267 - A1267
  • [37] Pathogenic significance of α-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus type 1
    Yamamoto, N
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (03) : 262 - 271
  • [38] LYMPHOPROLIFERATIVE RESPONSES TO MITOGENS AND HIV-1 ENVELOPE GLYCOPROTEIN AMONG VOLUNTEERS VACCINATED WITH RECOMBINANT-GP160
    TACKET, CO
    BAQAR, S
    MUNOZ, C
    MURPHY, JR
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (04) : 535 - 542
  • [39] Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs
    Mobley, PW
    Waring, AJ
    Sherman, MA
    Gordon, LM
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1418 (01): : 1 - 18
  • [40] N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus
    Dey, Antu K.
    David, Kathryn B.
    Ray, Neelanjana
    Ketas, Thomas J.
    Klasse, Per J.
    Doms, Robert W.
    Moore, John P.
    VIROLOGY, 2008, 372 (01) : 187 - 200